Search

everythinglearnresearchcommunity

for

Search:↓

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

AMT may cause hair loss and changing dWAT activity could help treat it.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Collagen networks play a key role in hair loss and follicle miniaturization.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Curly hair in certain scalp areas can be an early sign of hair loss.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Women with PCOS have altered brain structure and reduced cognitive performance.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Mutations in certain receptors can cause diseases and offer new treatment options.